Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 8, 2011
Grant Date -
Mar 13, 2008
app pub date -
Jan 17, 2007
filing date -
Jan 17, 2006
priority date (Note) -
Expired
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
Methods for altering the N-glycosylation pattern of proteins in higher plants are provided. In some embodiments, the methods comprise introducing into a duckweed plant a recombinant RNAi construct that provides for the inhibition of expression of α1,3-fucosyltransferase (FucT) and β1,2-xylosyltransferase (XylT). Use of these RNAi constructs to inhibit or suppress expression of both of these enzymes, and isoforms thereof, advantageously provides for the production of endogenous and heterologous proteins having a “humanized” N-glycosylation pattern without impacting plant growth and development. Stably transformed higher plants, including duckweed plants, having this protein N-glycosylation pattern are provided. Glycoprotein compositions, including monoclonal antibody compositions, having substantially homogeneous glycosylation profiles, and which are substantially homogeneous for the G0 glycoform, are also provided.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
SYNTHON BIOPHARMACEUTICALS B V | 6545 CM NIJMEGEN |
International Classification(s)

- 2007 Application Filing Year
- C07H Class
- 2326 Applications Filed
- 871 Patents Issued To-Date
- 37.45 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Cox, Kevin M | Raleigh, US | 13 | 94 |
# of filed Patents : 13 Total Citations : 94 | |||
Dickey, Lynn F | Cary, US | 14 | 101 |
# of filed Patents : 14 Total Citations : 101 | |||
Peele, Charles G | Apex, US | 12 | 96 |
# of filed Patents : 12 Total Citations : 96 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 20 Citation Count
- C07H Class
- 69.30 % this patent is cited more than
- 14 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Mar 09, 2015 | STCH | INFORMATION ON STATUS: PATENT DISCONTINUATION | free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
Feb 08, 2015 | FP | LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE | Effective Date: Feb 08, 2015 |
Feb 08, 2015 | LAPS | LAPSE FOR FAILURE TO PAY MAINTENANCE FEES | |
Sep 19, 2014 | REMI | MAINTENANCE FEE REMINDER MAILED | |
Dec 04, 2012 | FEPP | FEE PAYMENT PROCEDURE | free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
Apr 19, 2012 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOLEX THERAPEUTICS, INC.;REEL/FRAME:028278/0729 Owner name: SYNTHON BIOPHARMACEUTICALS B.V., NETHERLANDS Effective Date: Apr 19, 2012 |
Apr 19, 2012 | AS | ASSIGNMENT | free format text: RELEASE OF SECURITY INTEREST;ASSIGNOR:MIDCAP FINANCIAL SBIC, LP;REEL/FRAME:028276/0548 Owner name: BIOLEX THERAPEUTICS, INC., NORTH CAROLINA Effective Date: Apr 19, 2012 |
Sep 20, 2011 | CC | CERTIFICATE OF CORRECTION | |
Feb 08, 2011 | I | Issuance | |
Oct 01, 2010 | AS� | SECURITY INTEREST | free format text: SECURITY AGREEMENT;ASSIGNOR:BIOLEX THERAPEUTICS, INC.;REEL/FRAME:025333/0026 Owner name: MIDCAP FINANCIAL SBIC, LP, MARYLAND Effective Date: Oct 01, 2010 |
Mar 13, 2008 | P | Published | |
Nov 13, 2007 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DICKEY, LYNN F.;COX, KEVIN M.;PEELE, CHARLES G.;REEL/FRAME:021195/0646 Owner name: BIOLEX, INC., NORTH CAROLINA Effective Date: Nov 13, 2007 |
Oct 12, 2007 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION;REEL/FRAME:025240/0766 Owner name: BIOLEX, INC., NORTH CAROLINA Effective Date: Oct 12, 2007 |
Oct 11, 2007 | AS | ASSIGNMENT | free format text: CHANGE OF NAME;ASSIGNOR:BIOLEX, INC.;REEL/FRAME:020487/0980 Owner name: BIOLEX THERAPEUTICS, INC., NORTH CAROLINA Effective Date: Oct 11, 2007 free format text: CHANGE OF NAME;ASSIGNOR:BIOLEX, INC.;REEL/FRAME:020487/0980 Owner name: BIOLEX THERAPEUTICS, INC.,NORTH CAROLINA Effective Date: Oct 11, 2007 |
Jan 17, 2007 | F | Filing | |
Jan 17, 2006 | PD | Priority Date |

Matter Detail

Renewals Detail
